Author | Jordi Bruix, MD | OncLive

Author | Jordi Bruix, MD

Articles

Dr. Bruix Discusses Progress of Second-Line Treatment in HCC

July 10, 2017

Video

Jordi Bruix, MD, head of the Barcelona Clinic Liver Cancer at University of Barcelona, discusses the impact of the recent progress in the second-line treatment setting for hepatocellular carcinoma.

Dr. Bruix Discusses the Updated Findings of the RESORCE Trial in HCC

June 29, 2017

Video

Jordi Bruix, MD, head of the Barcelona Clinic Liver Cancer (BCLC) at University of Barcelona, discusses the updated findings of the RESORCE Trial in hepatocellular carcinoma.

Dr. Bruix Discusses the Application of Regorafenib in HCC

April 28, 2017

Video

Jordi Bruix, MD, head of the Barcelona Clinic Liver Cancer (BCLC) at University of Barcelona, discusses the application of regorafenib (Stivarga) in hepatocellular carcinoma as opposed to other tumor types.

Dr. Bruix Discusses the Success of Regorafenib in HCC

April 22, 2017

Video

Jordi Bruix, MD, head of the Barcelona Clinic Liver Cancer (BCLC) at University of Barcelona, discusses the recent success of regorafenib (Stivarga) in hepatocellular carcinoma (HCC) and its impact on the field.

x